Podcast

Vikas Majithia, MD, on New and Existing Treatments for AxSpA

08/19/2022

Dr Majithia discusses the options for treating axial spondyloarthritis, including the newest approved agent, upadacitinib.

Vikas Majithia, MD, is chair of the Division of Rheumatology and a senior associate consultant in the Department of Medicine at Mayo Clinic-Florida in Jacksonville.

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

Quiz

Quiz: Arthritis

07/04/2019

Which is the most common form of arthritis?An estimated 78 million US adults aged 18 years or older are projected to have doctor-diagnosed arthritis by what year?Among individuals with arthritis, what percentage...

Which...

07/04/2019

Rheumatology & Arthritis

ACR, Arthritis Foundation Release Guideline for Manifestations of JIA

05/08/2019

The American College of Rheumatology (ACR) and the Arthritis Foundation have released an updated guideline for the treatment of juvenile idiopathic arthritis (JIA), specifically addressing therapeutic approaches...

The...

05/08/2019

Rheumatology & Arthritis

Opioid Use in Osteoarthritis Is Largely Affected by Geography

01/28/2019

The percentage of individuals with advanced osteoarthritis receiving opioids as long-term treatment varies greatly from state to state, according to a new study.1   "These findings suggest that regional...

The...

01/28/2019

Rheumatology & Arthritis

Poll

Poll: Vitamin D and Rheumatoid Arthritis

11/06/2018

Are deficient vitamin D levels associated with increased disease severity in patients with rheumatoid arthritis?IncorrectThe correct answer is "yes." Read more about the study here.Correct!Read more about the study...

Are...

11/06/2018

Rheumatology & Arthritis

Start Moving, Start Living

07/31/2018

Rheumatology & Arthritis

Vikas Majithia, MD, on New and Existing Treatments for AxSpA

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products